Cargando…
AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
OBJECTIVES: There is no consensus regarding whether androgen deprivation therapy (ADT) is associated with cardiovascular disease (CVD) and cardiovascular mortality (CVM). The objective of this study was to determine the role of ADT for prostate cancer (PCa) in development of cardiovascular events (C...
Autores principales: | Niu, Yuanjie, Zhu, Shimiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842532/ http://dx.doi.org/10.21037/tau.2016.s187 |
Ejemplares similares
-
AB125. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2015) -
AB188. Vasohibin-1 and microvessel density predict prognosis in clear cell renal cell carcinoma
por: Tian, Hao, et al.
Publicado: (2016) -
AB177. Clinical and pathological research of prostate cancer with Gleason score 10
por: Yan, Bin, et al.
Publicado: (2016) -
AB093. C1QBP regulates YBX1 to suppress the androgen receptor (AR)-enhanced RCC cell invasion
por: Wang, Yong, et al.
Publicado: (2017) -
AB070. Roles and mechanisms of soybean isoflavones in androgen-independent transformation of prostate cancer
por: Xu, Li, et al.
Publicado: (2017)